IFNL3 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:282617, HGNC:18365, IFN-lambda-3, IFN-lambda-4, IFNL3, IL-28B, IL-28C, IL28B, IL28C, MIM:607402, NM_001346937, NM_172139, NP_001333866, NP_742151, interferon lambda 3

Id:ENSG00000197110

Entrez:282617

Ensembl:ENSG00000197110

Description:interferon lambda 3

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View IFNL3's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with IFNL3.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using IFNL3.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for IFNL3.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with IFNL3.

Results found

Linked to

	Label	Description
	GSE206931 WDR5 inhibition WIN 8 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150895 GSE150896 enzalutamide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 2 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150895,GSE150896 0 V 1 ENZALUTAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE184784 FACT SUPT16H inhibition Activated natural killer cell therapy 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE221577 PIK3R1 knockout 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE142210 9 V 10 PANOBINOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE237216 STAT1 knockout RPMI-8226 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 paclitaxel R1192 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE142210 11 V 7 PANOBINOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 8 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE150895 GSE150896 enzalutamide 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE150895,GSE150896 0 V 1 ENZALUTAMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE184784 FACT SUPT16H inhibition Activated natural killer cell therapy 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE221577 PIK3R1 knockout 3 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE142210 9 V 10 PANOBINOSTAT HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE237216 STAT1 knockout RPMI-8226 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE228106 paclitaxel R1192 3 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE142210 11 V 7 PANOBINOSTAT HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.